SITE007-0021

SITE007 (JPN) › SITE007-0021

SITE007-0021

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2025-09-11

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-12-20 (study day 268); relationship: NOT RELATED

moderate assessed

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-10-28 (study day 215); relationship: NOT RELATED

mild assessed

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-09 (study day 104); relationship: NOT RELATED

moderate assessed

Grade 2 Hepatitis — outcome: RECOVERED/RESOLVED; onset 2022-07-06 (study day 101); relationship: RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.